News


All News

Epidermolysis bullosa (EB) is often described as ‘the worst disease you’ve never heard of,’ and the young sufferer of this condition are referred to as ‘butterfly children’ because their skin is said to be fragile as the wings of butterflies. A potential new topical treatment option, in phase 3 trials, could help to change the EB treatment landscape.

Even the most brilliant physicians often lack the capacity to see inside their own heads or view themselves as others see them. They may neglect or fail to notice the obvious: Burnout, violation of boundaries, depression, anger, substance abuse. Or they may understand they’re in trouble, but fear letting anyone know about their struggles. Help is available when physicians need a path back to professional health. Learn more

Up to 90% of young victims present with cutaneous findings; however, only 8% of the 90% of skin abnormalities due to child abuse are pathognomonic. The diagnosis of child abuse should be evaluated by a multidisciplinary team of expert specialists. Learn what to look for.

When routine skin injuries such as mild burns, skin tears, uncomplicated stasis ulcers and minor post-operative wound complications become a routine part of the wound care center purview and are no longer considered a part of what dermatologists can do or wish to do, the dermatology discipline shrinks further toward a marginalized specialty. Learn more

The stories of the heroes behind these and other dermatologic therapeutic discoveries are recounted in the book To Heal the Skin: The Heroes Behind Discoveries in Dermatology edited by the late Stuart Maddin, M.D., F.R.C.P.C., professor emeritus at the University of British Columbia (UBC) in Vancouver, Canada, and a leader and pioneer in dermatology in Canada and internationally, and Eileen Murray, M.D., F.R.C.P.C., a dermatologist and adjunct professor at UBC. Learn more

A newly approved medication called sonidegib (Odomzo) gives physicians a second option in a class of medications designed to treat a small number of patients who suffer from locally advanced basal cell carcinoma and meet other criteria. Learn more

Dermatology Times editorial advisor, Dr. Elaine Siegfried continues the discussion on isotretinoin with Jim Leyden, M.D., emeritus professor of dermatology at the University of Pennsylvania. In this final segment, the two discuss whether a waiting period is necessary before treating acne scars and the questionable existence of pityrosporum folliculitis.

Because mole melanocytes have high levels of p15 while it’s depleted in melanomas, knowing P15 status may in the future help clinicians better diagnose ambiguous biopsies.

New and exciting topical and oral therapeutic agents and those still in the pipeline are slated to revolutionize acne therapy, as they appear to more effectively improve the clinical symptoms of acne.

In the midst of a changing healthcare climate, increased patient loads, new technologies, dermatologists are feeling the stress. Is there one particular pain point that is more important than another? You tell us and we’ll share the collected, anonymous responses in an upcoming post!

There’s nothing quite like curling up with a good book, especially during the cold winter months. Dermatologists on Dermatology Times’ editorial board shared the recent books they said might make great holiday reads.

With 2015 coming to a close and Thanksgiving around the corner, we asked Dermatology Times editorial board members and fellow dermatologists what makes them grateful, when they look back on the year. Here’s what they had to say.